Name
Competence Centre for Cancer Research AS
Registry code
11015418
VAT number
EE100883541
Type
AS - Joint Stock Company
Status
Registered
Foundation date
13.02.2004 (22)
Financial year
01.01-31.12
Capital
50 000.00 €
Activity
70201 -
5 000 €
-1 562 €
-31%
-
66 778 €
0
Submitted
No tax arrears
-2%
-1%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Reena Singh
| - | - | Indirect ownership |
| Rakesh Pandey
| - | Board member | Indirect ownership |
| AS Bravo Pharmaceuticals 14159974 | 65% - 32 500.00 EUR | - | - |
| Nishant Kumar
| 35% - 17 500.00 EUR | - | Direct ownership |
| Owner | Representative | Beneficial owner |
|---|
| 2019 05.05.2021 | 2020 10.09.2021 | 2021 22.06.2022 | 2022 26.09.2023 | 2023 08.07.2024 | 2024 14.07.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 71 718 € | 53 269 € | 2 758 € | 0 € | 28 500 € | 5 000 € |
| Net profit (loss) for the period | 52 878 € | -32 563 € | -617 € | 129 € | 3 035 € | -1 562 € |
| Profit Margin | 74% | -61% | -22% | - | 11% | -31% |
| Current Assets | 98 999 € | 100 836 € | 101 195 € | 101 236 € | 104 272 € | 102 713 € |
| Fixed Assets | 3 148 € | 30 056 € | 29 080 € | 29 080 € | 29 080 € | 29 080 € |
| Total Assets | 102 147 € | 130 892 € | 130 275 € | 130 316 € | 133 352 € | 131 793 € |
| Current Liabilities | 3 792 € | 100 € | 100 € | 12 € | 12 € | 15 € |
| Non Current Liabilities | 0 € | 65 000 € | 65 000 € | 65 000 € | 65 000 € | 65 000 € |
| Total Liabilities | - | 65 100 € | 65 100 € | 65 012 € | 65 012 € | 65 015 € |
| Share Capital | 50 000 € | 50 000 € | 50 000 € | 50 000 € | 50 000 € | 50 000 € |
| Equity | 98 355 € | 65 792 € | 65 175 € | 65 304 € | 68 340 € | 66 778 € |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 0 € | - | - | - |
| 2025 Q3 | 0 € | - | - | - |
| 2025 Q2 | 0 € | - | - | - |
| 2025 Q1 | 0 € | - | - | - |
| 2024 Q4 | 0 € | - | - | - |
| 2024 Q3 | 0 € | 0 € | 0 € | - |
| 2024 Q2 | 0 € | 0 € | 0 € | - |
| 2024 Q1 | 14 000 € | 0 € | 0 € | - |
| 2023 Q4 | 19 500 € | 0 € | 464 € | - |
| 2023 Q3 | 0 € | - | - | - |
| 2023 Q2 | 0 € | - | - | - |
| 2023 Q1 | 0 € | - | - | - |
| 2022 Q4 | 0 € | - | - | - |
| 2022 Q3 | 0 € | - | - | - |
| 2022 Q2 | 0 € | - | - | - |
| 2022 Q1 | 0 € | - | - | - |
